Report overview
Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry eye, and the Others one is evaporative dry eye. Dry eye syndrome is one of the most common eye disorders around the world and is particularly common in the geriatric demographic. Reduction in the production of tears due to aging is the primary cause of dry eye syndrome among the elderly.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Drugs and Devices Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Drugs and Devices Treatment. This report contains market size and forecasts of Dry Eye Drugs and Devices Treatment in global, including the following market information:
Global Dry Eye Drugs and Devices Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Dry Eye Drugs and Devices Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the global market. The region is projected to account for a significant share of the global dry eye drugs and devices treatment market during the forecast period due to a high incidence of dry eye disease among the American population.
We surveyed the Dry Eye Drugs and Devices Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Eye Drugs and Devices Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, by Type, 2022 (%)
Antibiotic Drops
Hormone Drops
Artificial Tears
Others
Global Dry Eye Drugs and Devices Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Dry Eye Drugs and Devices Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Eye Drugs and Devices Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dry Eye Drugs and Devices Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Merck
Johnson & Johnson
EyeGate Pharmaceuticals
Allergan
Takeda
Jianfeng Group
Bausch Health
Santen Pharmaceutical
Senju Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dry Eye Drugs and Devices Treatment, market overview.
Chapter 2: Global Dry Eye Drugs and Devices Treatment market size in revenue.
Chapter 3: Detailed analysis of Dry Eye Drugs and Devices Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye Drugs and Devices Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
